Ocular pathology in multiple sclerosis: Retinal atrophy and inflammation irrespective of disease duration

Brain

Volumn 133, Issue 6, 2010, Pages 1591-1601

  Green, Ari J ^a   McQuaid, Stephen ^c   Hauser, Stephen L ^a   Allen, Ingrid V ^b   Lyness, Roy ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Eye; Inflammation; Multiple sclerosis; Ocular pathology; Retinal periphlebitis

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; HLA DR ANTIGEN;

ADULT; AGED; ARTICLE; ASTROCYTE; AUTOPSY; AXONAL INJURY; BRAIN ATROPHY; BRAIN WEIGHT; CELL DENSITY; CELL LOSS; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLIOSIS; HUMAN; HUMAN TISSUE; IRIS DISEASE; MAJOR CLINICAL STUDY; MALE; MICROGLIA; MULTIPLE SCLEROSIS; NERVE FIBER; NEUROFILAMENT; OPTIC DISK; OPTIC NERVE; PHENOTYPE; PHLEBITIS; PRIORITY JOURNAL; RETINA ATROPHY; RETINA DISEASE; RETINA GANGLION CELL; RETINA NERVE CELL; RETINA PERIPHLEBITIS; RETINITIS;

ACUTE DISEASE; ADULT; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NERVOUS SYSTEM DISEASES; RETINA; RETINAL DEGENERATION; RETINITIS; TIME FACTORS;

EID: 77952991172     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq080     Document Type: Article

References (54)

1. Arnold C. Evolving management of optic neuritis and multiple sclerosis. J Ophthalmol 2005; 139: 1101-1108
2. Arnold AC, Pepose JS, Hepler RS, Foos RY. Retinal periphlebitis and retinitis in multiple sclerosis. I. Pathologic characteristics. Ophthalmology 1984; 91: 255-262
3. Balcer LJ. Optic Neuritis. N Engl J Med 2006; 354: 1273-1280
4. Birch MK, Barbosa S, Blumhardt LD, O'Brien C, Harding SP. Retinal venous sheathing and the blood-retinal barrier in multiple sclerosis. Arch Ophthalmol 1996; 114: 34-39
5. Biousse V, Trichet C, Bloch-Michel E, Roullet E. Multiple sclerosis associated with uveitis in two large clinic-based series. Neurology 1999; 52: 179-181
6. Blumenthal EZ, Parikh RS, Pe'er J, Naik M, Kaliner E, Cohen MJ, et al. Retinal nerve fibre layer imaging compared with histological measurements in a human eye. Eye 2009; 23: 171-175
7. Brück W, Bitsch A, Kolenda H, Brück Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997; 42: 783-793
8. Costello F, Coupland S, Hodge W, Lorello GR, Koroluk J, Pan YI, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006; 59: 963-969
9. Coupland SG, Kirkham TH. Flash electroretinogram abnormalities in patients with clinically definite multiple sclerosis. Can J Neurol Sci 1982; 9: 325-330
10. De Stefano N, Battaglini M, Smith SM. Measuring brain atrophy in multiple sclerosis. J Neuroimaging 2007; 17(Suppl 1): 10S-15S.
11. Dutt M, Tabuena P, Ventura E, Rostami A, Shindler KS. Timing of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritis. Invest Ophthalmol Vis Sci 2009 Nov 5. [Epub ahead of print].
12. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 2001; 124: 1813-1820
13. Evans JR, Fletcher AE, Wormald RP. Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Ophthalmology 2004; 111: 513-517
14. Forooghian F, Sproule M, Westall C, Gordon L, Jirawuthiworavong G, Shimazaki K, et al. Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies. Doc Ophthalmol 2006; 113: 123-132
15. Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006; 113: 324-332
16. Fog T. The topography of plaques in multiple sclerosis. Acta Neurol 1965; 41(suppl 15): 154-156
17. Frisén L, Hoyt WF. Insidious atrophy of retinal nerve fibers in multiple sclerosis. Funduscopic identification in patients with and without visual complaints. Arch Ophthalmol 1974; 92: 91-97
18. Gartner S. Optic neuropathy in multiple sclerosis; optic neuritis. AMA Arch Ophthalmol 1953; 50: 718-726
19. Graham EM, Francis DA, Sanders MD, Rudge P. Ocular inflammatory changes in established multiple sclerosis. J Neurol Neurosurg Psychiatry 1989; 52: 1360-1363
20. Gupta N, Yucel YH. Glaucoma as a neurodegenerative disease. Curr Opin Ophthalmol 2007; 18: 110-114
21. Henderson AP, Trip SA, Schlottmann PG, Altmann DR, Garway-Heath DF, Plant GT, et al. An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain 2008; 13: 277-287
22. Hobom M, Storch MK, Weissert R, Maier K, Radhakrishnan A, Kramer B, et al. Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis. Brain Pathol 2004; 14: 148-157
23. Jindahra P, Petrie A, Plant GT. Retrograde trans-synaptic retinal ganglion cell loss identified by optical coherence tomography. Brain 2009; 132: 628-634
24. Kerrison JB, Flynn T, Green WR. Retinal pathologic changes in multiple sclerosis. Retina 1994; 14: 445-451
25. Krishnamoorthy G, Saxena A, Mars LT, Domingues HS, Mentele R, Ben-Nun A, et al. Myelin-specific T cells also recognize neuronal auto-antigen in a transgenic mouse model of multiple sclerosis. Nat Med 2009; 15: 626-632
26. Korsholm K, Madsen KH, Frederiksen JL, Skimminge A, Lund TE. Recovery from optic neuritis: an ROI-based analysis of LGN and visual cortical areas. Brain 2007; 130: 1244-1253
27. Kroese M, Burton H, Vardy S, Rimmer T, McCarter D. Prevalence of primary open angle glaucoma in general ophthalmic practice in the United Kingdom. Br J Ophthalmol 2002; 86: 978-980
28. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Bruck W, Rauschka H, Bergmann M, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705-2712
29. Le Scanff J, Sève P, Renoux C, Broussolle C, Confavreux C, Vukusic S. Uveitis associated with multiple sclerosis. Mult Scler 2008; 14: 415-417
30. Lei Y, Garrahan N, Hermann B, Becker DL, Hernandez MR, Boulton ME, et al. Quantification of retinal transneuronal degeneration in human glaucoma: a novel multiphoton-DAPI approach. Invest Ophthalmol Vis Sci 2008; 49: 1940-1945
31. Lisch K. Die Veranderung der peripheren schbahn bei Mulipler Sklerose Arch f. Augehn 1933; 107: 380.
32. Lumsden CE. The Neuropathology of multiple sclerosis. In: Vinken PJ, Gruyn GW, editors. Handbook of Clinical Neurology. Vol.9. (Chapter 8) Amsterdam: North Holland; 1970. p. 217-309.
33. Madigan MC, Rao NS, Tenhula WN, Sadun AA. Preliminary morpho-metric study of tumor necrosis factor-alpha (TNF alpha)-induced rabbit optic neuropathy. Neurol Res 1996; 18: 233-236
34. Mogensen PH. Histopathology of anterior parts of the optic pathway in patients with multiplesclerose. Acta Ophthalmol 1990; 68: 218-220
35. Nihmaille AN, McQuaid S, Windebank A, Cunnea P, McMahon J, Samali A, et al. Increased expression of endoplasmic reticulum stress-related signaling pathway molecules in multiple sclerosis lesions. J Neuropathol Exp Neurol 2008; 67: 200-211
36. Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis. Arch Neurol 2008; 65: 727-732
37. Oppenheim H. Zur pathologie der disseminirten sklerose. Berliner Klinische Wochenschrift 1887; 48: 904-907
38. Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 1999; 40: 2520-2527
39. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-231
40. Rucker CW. Sheathing of the retinal veins in multiple sclerosis. Mayo Clinic Proc 1944; 19: 176-178
41. Rucker CW. Sheathing of the retinal veins in multiple sclerosis. Review of pertinent literature. Mayo Clin Proc 1972; 47: 335-340
42. Sanders MD. Retinal arteritis, retinal vasculitis and autoimmune retinal vasculitis. Eye 1987; 1: 441-465
43. Schlossman A, Phillips CC. Optic neuritis in relation to demyelinating diseases. Am J Ophthalomol 1954; 37: 487-494
44. Schmidt S, Wessels L, Augustin A, Klockgether T. Patients with Multiple Sclerosis and concomitant uveitis/periphlebitis retinae are not distinct from those without intraocular inflammation. J Neurol Sci 2001; 187: 49-53.
45. Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, García-Layana A, Bejarano B, Villoslada P. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology 2007; 68: 1488-1494
46. Shaw PJ, Smith NM, Ince PG, Bates D. Chrnoic periphlebitis retinae in multiple sclerosis. A histopathological study. J Neurol Sci 1987; 77: 147-152
47. Shindler KS, Ventura E, Dutt M, Rostami A. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Exp Eye Res 2008; 87: 208-213
48. ter Braak JWG, van Herwaarden A. Ophthalmo-encephalomyelitis. Klin Monatsbl Augenheilkd 1933; 91: 316-343
49. Toussaint D, Périer O, Verstappen A, Bervoets S. Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol 1983; 3: 211-220
50. Trip SA, Schlottmann PG, Jones SJ, Altmann DR, Garway-Heath DF, Thompson AJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005; 58: 383-391
51. van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999; 46: 747-754
52. Ulrich J, Groebke-Lorenz W. The optic nerve in multiple sclerosis: a morphological study with retrospective clinicopathological correlations. Neuro-Ophthalmology 1983; 3: 149-159
53. Yang P, Das PK, Kijlstra A. Localization and characterization of immu-nocompetent cells in the human retina. Ocul Immunol Inflamm 2000; 8: 149-157
54. Youl BD, Turano G, Miller DH, Towell AD, MacManus DG, Moore SG, et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 1991; 114: 2437-2450